Genetics of inflammatory bowel disease - The beginning of the end or the end of the beginning?

被引：20

作者：

Annese, V ^{[1
]}

Latiano, A

Andriulli, A

机构：

[1] Casa Sollievo Sofferenza Hosp, IRCCS, Dept Internal Med, Gastroenterol Unit, I-71013 San Giovanni Rotondo, FG, Italy

[2] Casa Sollievo Sofferenza Hosp, IRCCS, Mol Biol Lab, I-71013 San Giovanni Rotondo, FG, Italy

来源：

DIGESTIVE AND LIVER DISEASE | 2003年 / 35卷 / 06期

关键词：

Crohn's disease; gene; inflammatory bowel disease; NOD2/CARD(15); ulcerative colitis;

D O I：

10.1016/S1590-8658(03)00213-5

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Recent identification of the first susceptibility gene for Crohn's disease has led to increasing enthusiasm for the investigation and dissection of inflammatory bowel disease. In the future, identification of additional genes and careful correlation of the genetic background with clinical features of the disease will help to elucidate the causes and cure of inflammatory bowel disease. However, caution is still needed in the short term since our present knowledge has limited influence on clinical management. This review focuses on the genetic background of inflammatory bowel disease, the process of discovering the mutations of the NOD2/CARD(15) gene in Crohn's disease patients, and the functional clues of the genetic variants of this gene in relation to clinical features. (C) 2003 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Science Ltd. All rights reserved.

引用

页码：442 / 449

页数：8

共 62 条

[1] Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease
Abreu, MT
Taylor, KD
Lin, YC
Hang, T
Gaiennie, J
Landers, CJ
Vasiliauskas, EA
Kam, LY
Rojany, M
Papadakis, KA
Rotter, JI
Targan, SR
Yang, HY
[J]. GASTROENTEROLOGY, 2002, 123 (03) : 679 - 688
[2] The molecular classification of the clinical manifestations of Crohn's disease
Ahmad, T
Armuzzi, A
Bunce, M
Mulcahy-Hawes, K
Marshall, SE
Orchard, TR
Crawshaw, J
Large, O
De Silva, A
Cook, JT
Barnardo, M
Cullen, S
Welsh, KI
Jewell, DP
[J]. GASTROENTEROLOGY, 2002, 122 (04) : 854 - 866
[3] Review Article: The genetics of inflammatory bowel disease
Ahmad, T
Satsangi, J
Mcgovern, D
Bunce, M
Jewell, DP
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (06) : 731 - 748
[4] Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus -: A GISC study
Annese, V
Latiano, A
Bovio, P
Forabosco, P
Piepoli, A
Lombardi, G
Andreoli, A
Astegiano, M
Gionchetti, P
Riegler, G
Sturniolo, GC
Clementi, M
Rappaport, E
Fortina, P
Devoto, M
Gasparini, P
Andriulli, A
[J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 1999, 7 (05) : 567 - 573
[5] Annese V, 2002, GASTROENTEROLOGY, V122, pA296
[6] Annese V, 2001, AM J GASTROENTEROL, V96, P2939
[7] TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
Arbour, NC
Lorenz, E
Schutte, BC
Zabner, J
Kline, JN
Jones, M
Frees, K
Watt, JL
Schwartz, DA
[J]. NATURE GENETICS, 2000, 25 (02) : 187 - +
[8] Crohn's disease: Concordance for site and clinical type in affected family members - Potential hereditary influences
Bayless, TM
Tokayer, AZ
Polito, JM
Quaskey, SA
Mellits, ED
Harris, ML
[J]. GASTROENTEROLOGY, 1996, 111 (03) : 573 - 579
[9] Autoimmunity and apoptosis: The Crohn's connection
Beutler, B
[J]. IMMUNITY, 2001, 15 (01) : 5 - 14
[10] Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan
Bonen, DK
Ogura, Y
Nicolae, DL
Inohara, N
Saab, L
Tanabe, T
Chen, FF
Foster, SJ
Duerr, RH
Brant, SR
Cho, JH
Nuñez, G
[J]. GASTROENTEROLOGY, 2003, 124 (01) : 140 - 146

← 1 2 3 4 5 6 7 →